Beijing Securities 50 up 0.30%, 6 stocks from the Beijing Stock Exchange make the list, including Longyuan Co., Ltd., Pu'ang Medical, etc. (with list)

Tongbiancai News, on April 2, 2026, the Beiqing 50 rose 0.30%, and individual stocks listed on the Beijing Stock Exchange, including Longyuan Co., Ltd., Pu’ang Medical, Zu Xing New Materials, Keli Co., Ltd., Yuelong Technology, and more, appeared on the龙虎榜.

Among them:

Longyuan Co., Ltd. (920055) fell 1.18%, closing at 34.29 yuan. Its circulating market cap was 525 million yuan, and its turnover rate was 27.58%. Reason for the listing: Among the day’s top 5 stocks by turnover rate, the turnover rate reached 20%. 龙虎榜 buy amount was 32.4733 million yuan,龙虎榜 sell amount was 19.3013 million yuan, and龙虎榜 net buy amount was 13.1719 million yuan. The first buy seat was the Hubei Construction Avenue Guangfa Bank Building business department of 广发证券股份有限公司, buying 11.8849 million yuan; the first sell seat was the Shenzhen Hongling Middle Road securities business department of 国信证券股份有限公司, selling 4.5596 million yuan.

Pu’ang Medical (920069) rose 3.38%, closing at 37.95 yuan. Its circulating market cap was 561 million yuan, and its turnover rate was 28.28%. Reason for the listing: Among the day’s top 5 stocks by turnover rate, the turnover rate reached 20%. 龙虎榜 buy amount was 18.6177 million yuan,龙虎榜 sell amount was 24.7273 million yuan, and龙虎榜 net buy amount was -6.1096 million yuan. The first buy seat was an institution-only seat, buying 4.1844 million yuan; the first sell seat was the Zhejiang Branch of 国信证券股份有限公司, selling 11.9480 million yuan.

Zu Xing New Materials (920078) fell 3.29%, closing at 25.90 yuan. Its circulating market cap was 536 million yuan, and its turnover rate was 26.17%. Reason for the listing: Among the day’s top 5 stocks by turnover rate, the turnover rate reached 20%. 龙虎榜 buy amount was 19.2349 million yuan,龙虎榜 sell amount was 24.7494 million yuan, and龙虎榜 net buy amount was -5.5144 million yuan. The first buy seat was an institution-only seat, buying 5.0014 million yuan; the first sell seat was an institution-only seat, selling 6.9679 million yuan.

Keli Co., Ltd. (920088) rose 15.76%, closing at 61.98 yuan. Its circulating market cap was 1.99B yuan, and its turnover rate was 38.95%. Reason for the listing: Among the day’s top 5 stocks by turnover rate, the turnover rate reached 20%. 龙虎榜 buy amount was 91.4543 million yuan,龙虎榜 sell amount was 119.0 million yuan, and龙虎榜 net buy amount was -27.7953 million yuan. The first buy seat was the Shenzhen Internet Branch of 国信证券股份有限公司, buying 23.9170 million yuan; the first sell seat was the Shenzhen Internet Branch of 国信证券股份有限公司, selling 45.7592 million yuan.

Yuelong Technology (920188) rose 3.42%, closing at 25.42 yuan. Its circulating market cap was 503 million yuan, and its turnover rate was 38.37%. Reason for the listing: Among the day’s top 5 stocks by turnover rate, the turnover rate reached 20%. 龙虎榜 buy amount was 23.8914 million yuan,龙虎榜 sell amount was 26.9606 million yuan, and龙虎榜 net buy amount was -3.0692 million yuan. The first buy seat was the Shenzhen High-Tech Park business department of 国泰海通证券股份有限公司, buying 4.8875 million yuan; the first sell seat was the Chongqing Jinzhou Avenue securities business department of 东方证券股份有限公司, selling 7.2830 million yuan.

O’Kang Biopharma (920230) rose 29.98%, closing at 14.61 yuan. Its circulating market cap was 690 million yuan, and its turnover rate was 25.10%. Reason for the listing: Among the day’s top 5 stocks by closing price gain, the closing price gain reached 20%. 龙虎榜 buy amount was 45.7353 million yuan,龙虎榜 sell amount was 27.0779 million yuan, and龙虎榜 net buy amount was 18.6573 million yuan. The first buy seat was the Changshu Southeast Avenue securities business department of 东莞证券股份有限公司, buying 15.7430 million yuan; the first sell seat was the Changshu Suolan South Road securities business department of 中信建投证券股份有限公司, selling 9.9495 million yuan.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin